{"id":44328,"date":"2025-10-24T23:37:15","date_gmt":"2025-10-24T15:37:15","guid":{"rendered":"https:\/\/flcube.com\/?p=44328"},"modified":"2025-10-24T23:37:16","modified_gmt":"2025-10-24T15:37:16","slug":"nmpa-expands-reference-listed-drugs-list-to-98-items-for-chemical-generic-drugs","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=44328","title":{"rendered":"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs"},"content":{"rendered":"\n<p>China\u2019s National Medical Products Administration (NMPA) today released its 98th Reference Listed Drugs (RLD) list for chemical generic drugs, adding <strong>60 drug specifications<\/strong> to the catalogue. The update includes <strong>42 specifications for original brand\u2011name drugs that have not yet been imported into China<\/strong>, signalling a broader push to streamline generic drug approvals and increase access to essential medicines.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-highlights\"><strong>Key Highlights<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Total Specifications Added<\/strong> \u2013 60 items, bringing the overall RLD count to 98.<\/li>\n\n\n\n<li><strong>Unimported Brand\u2011Name Drugs<\/strong> \u2013 42 specifications represent original brand\u2011name drugs that remain unavailable in the Chinese market.<\/li>\n\n\n\n<li><strong>Regulatory Impact<\/strong> \u2013 The new list will facilitate the review of generic applications, potentially accelerating market entry for both domestic and foreign manufacturers.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-the-rld-list-means-for-china-s-pharmaceutical-landscape\"><strong>What the RLD List Means for China\u2019s Pharmaceutical Landscape<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Accelerated Approval Pathways<\/strong> \u2013 Generic manufacturers can reference the new RLD specifications to expedite their approval processes under the \u201cgeneric drug registration\u201d framework.<\/li>\n\n\n\n<li><strong>Enhanced Drug Availability<\/strong> \u2013 Inclusion of unimported brand\u2011name drugs opens the door for Chinese firms to develop quality\u2011matched generics, boosting competition and lowering costs for patients.<\/li>\n\n\n\n<li><strong>Strategic Alignment<\/strong> \u2013 The update aligns with the Chinese government\u2019s \u201cMade in China 2025\u201d strategy to strengthen domestic innovation while maintaining rigorous safety and efficacy standards.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-next-steps-for-stakeholders\"><strong>Next Steps for Stakeholders<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Manufacturers<\/strong> \u2013 Review the full RLD list to identify opportunities for portfolio expansion and regulatory alignment.<\/li>\n\n\n\n<li><strong>Healthcare Providers<\/strong> \u2013 Stay informed on new generic options that may become available following regulatory clearance.<\/li>\n\n\n\n<li><strong>Investors<\/strong> \u2013 Monitor the pipeline of newly listed drugs for potential investment in emerging generic manufacturers.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-0cf87efa-dcb0-4552-b0a4-012dcc613ba4\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1761203264905091341.doc\">1761203264905091341<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1761203264905091341.doc\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-0cf87efa-dcb0-4552-b0a4-012dcc613ba4\">Download<\/a><\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China\u2019s National Medical Products Administration (NMPA) today released its 98th Reference Listed Drugs (RLD) list&#8230;<\/p>\n","protected":false},"author":1,"featured_media":44330,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[103],"class_list":["post-44328","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-gqce-testing"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China\u2019s National Medical Products Administration (NMPA) today released its 98th Reference Listed Drugs (RLD) list for chemical generic drugs, adding 60 drug specifications to the catalogue. The update includes 42 specifications for original brand\u2011name drugs that have not yet been imported into China, signalling a broader push to streamline generic drug approvals and increase access to essential medicines.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=44328\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs\" \/>\n<meta property=\"og:description\" content=\"China\u2019s National Medical Products Administration (NMPA) today released its 98th Reference Listed Drugs (RLD) list for chemical generic drugs, adding 60 drug specifications to the catalogue. The update includes 42 specifications for original brand\u2011name drugs that have not yet been imported into China, signalling a broader push to streamline generic drug approvals and increase access to essential medicines.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=44328\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-24T15:37:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-24T15:37:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2410.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44328#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44328\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs\",\"datePublished\":\"2025-10-24T15:37:15+00:00\",\"dateModified\":\"2025-10-24T15:37:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44328\"},\"wordCount\":278,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44328#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2410.webp\",\"keywords\":[\"GQCE testing\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=44328#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44328\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=44328\",\"name\":\"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44328#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44328#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2410.webp\",\"datePublished\":\"2025-10-24T15:37:15+00:00\",\"dateModified\":\"2025-10-24T15:37:16+00:00\",\"description\":\"China\u2019s National Medical Products Administration (NMPA) today released its 98th Reference Listed Drugs (RLD) list for chemical generic drugs, adding 60 drug specifications to the catalogue. The update includes 42 specifications for original brand\u2011name drugs that have not yet been imported into China, signalling a broader push to streamline generic drug approvals and increase access to essential medicines.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44328#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=44328\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44328#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2410.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2410.webp\",\"width\":1080,\"height\":608,\"caption\":\"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=44328#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs - Insight, China&#039;s Pharmaceutical Industry","description":"China\u2019s National Medical Products Administration (NMPA) today released its 98th Reference Listed Drugs (RLD) list for chemical generic drugs, adding 60 drug specifications to the catalogue. The update includes 42 specifications for original brand\u2011name drugs that have not yet been imported into China, signalling a broader push to streamline generic drug approvals and increase access to essential medicines.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=44328","og_locale":"en_US","og_type":"article","og_title":"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs","og_description":"China\u2019s National Medical Products Administration (NMPA) today released its 98th Reference Listed Drugs (RLD) list for chemical generic drugs, adding 60 drug specifications to the catalogue. The update includes 42 specifications for original brand\u2011name drugs that have not yet been imported into China, signalling a broader push to streamline generic drug approvals and increase access to essential medicines.","og_url":"https:\/\/flcube.com\/?p=44328","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-24T15:37:15+00:00","article_modified_time":"2025-10-24T15:37:16+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2410.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=44328#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=44328"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs","datePublished":"2025-10-24T15:37:15+00:00","dateModified":"2025-10-24T15:37:16+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=44328"},"wordCount":278,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=44328#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2410.webp","keywords":["GQCE testing"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=44328#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=44328","url":"https:\/\/flcube.com\/?p=44328","name":"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=44328#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=44328#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2410.webp","datePublished":"2025-10-24T15:37:15+00:00","dateModified":"2025-10-24T15:37:16+00:00","description":"China\u2019s National Medical Products Administration (NMPA) today released its 98th Reference Listed Drugs (RLD) list for chemical generic drugs, adding 60 drug specifications to the catalogue. The update includes 42 specifications for original brand\u2011name drugs that have not yet been imported into China, signalling a broader push to streamline generic drug approvals and increase access to essential medicines.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=44328#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=44328"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=44328#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2410.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2410.webp","width":1080,"height":608,"caption":"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=44328#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2410.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=44328"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44328\/revisions"}],"predecessor-version":[{"id":44331,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/44328\/revisions\/44331"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/44330"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=44328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=44328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=44328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}